Organogenesis Reviews

2.6
Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Geoff MacKay
10 Ratings
  • Helpful (1)

    Anonymous

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Organogenesis full-time

    Doesn't Recommend
    Negative Outlook
    No opinion of CEO
    Doesn't Recommend
    Negative Outlook
    No opinion of CEO

    Pros

    Great products and great people dedicated to helping patients get them. Many new people with optimistic attitudes. Smart and motivated.

    Cons

    Management disconnected and shortsighted. Too much infighting and blame placing. Lack of communication causes mistrust, changing reimbursement environment causing problems for business.

    Advice to Management

    Pay more attention to the people who got you here. Communicate better and more often with the staff. Notice the revolving door in some departments and take corrective action.


Organogenesis Interviews

Interview Experience

Interview Experience

16%
66%
16%

Getting an Interview

Getting an Interview

57%
14%
14%

Interview Difficulty

2.6
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Tissue Regeneration Specialist Interview

    Anonymous Interview Candidate
    Accepted Offer
    Neutral Experience
    Average Interview

    Application

    I applied in-person. The process took 3 weeksinterviewed at Organogenesis.

    Interview

    Four interviews total. Not very difficult. Typical questions. Give examples of sales success, situations, etc. Traveled for the last interview with multiple managers, human resources. Traveled for the last interview with multiple managers, human resources.

    Negotiation

    Easy

Organogenesis Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.organogenesis.com
Headquarters Canton, MA
Size 500 to 999 Employees
Founded 1985
Type Company - Private
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year
Competitors RTI Biologics

Organogenesis has the skinny on replacement tissue. Flagship product Apligraf is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds in some 250,000 patients; the company is developing a next-generation version of the material (using its VCT technology) using all human components. In addition to Apligraf, Organogenesis offers a line of biomaterials used in a range of surgical procedures to seal or... More

Work at Organogenesis? Share Your Experiences

Organogenesis

 
Click to Rate
or